公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2018 | 5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer's Disease Phenotypes | Lee H.-Y.; Fan S.-J.; Huang F.-I.; Chao H.-Y.; Hsu K.-C.; Lin T.E.; Yeh T.-K.; Lai M.-J.; Li Y.-H.; Huang H.-L.; CHIA-RON YANG ; Liou J.-P. | Journal of Medicinal Chemistry | 54 | 49 | |
2020 | Anti-Inflammatory and Tau Phosphorylation-Inhibitory Effects of Eupatin | Chou C.-H.; Hsu K.-C.; Lin T.E.; CHIA-RON YANG | Molecules (Basel, Switzerland) | 15 | 13 | |
2022 | Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment | Lin T.E.; CHIA-RON YANG ; Chou C.-H.; Hsu J.-Y.; Chao M.-W.; Sung T.-Y.; Hsieh J.-H.; Huang W.-J.; Hsu K.-C. | Biomedicine and Pharmacotherapy | 5 | 4 | |
2018 | Discovery of aliphatic-chain hydroxamates containing indole derivatives with potent class I histone deacetylase inhibitory activities | Chao S.-W.; Chen L.-C.; Yu C.-C.; Liu C.-Y.; Lin T.E.; JIH-HWA GUH ; Wang C.-Y.; Chen C.-Y.; Hsu K.-C.; Huang W.-J. | European Journal of Medicinal Chemistry | 20 | 17 | |
2022 | Identification and analysis of a selective DYRK1A inhibitor | Lin T.E.; Chao M.-W.; HuangFu W.-C.; Tu H.-J.; Peng Z.-X.; Su C.-J.; Sung T.-Y.; Hsieh J.-H.; Lee C.-C.; CHIA-RON YANG ; Pan S.-L.; Hsu K.-C. | Biomedicine and Pharmacotherapy | 6 | 3 | |
2021 | Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach | Chao M.-W.; Lin T.E.; HuangFu W.-C.; Chang C.-D.; Tu H.-J.; Chen L.-C.; Yen S.-C.; Sung T.-Y.; Huang W.-J.; CHIA-RON YANG ; Pan S.-L.; Hsu K.-C. | Journal of Enzyme Inhibition and Medicinal Chemistry | 9 | 8 | |
2020 | Magnolol, a novel antagonist of thrombin and par-1, inhibits thrombin-induced connective tissue growth factor (Ctgf) expression in vascular smooth muscle cells and ameliorate pathogenesis of restenosis in rats | Ko W.-C.; CHIA-TI TSAI ; Hsu K.-C.; Cheng Y.-C.; Lin T.E.; Chen Y.-L.; Hong C.-Y.; Lu W.-J.; Shih C.-M.; Yen T.-L. | Applied Sciences (Switzerland) | 2 | 2 | |
2022 | O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia | Yen S.-C.; Wu Y.-W.; Huang C.-C.; Chao M.-W.; Tu H.-J.; Chen L.-C.; Lin T.E.; Sung T.-Y.; Tseng H.-J.; Chu J.-C.; Huang W.-J.; CHIA-RON YANG ; HuangFu W.-C.; Pan S.-L.; Hsu K.-C. | Phytomedicine | 5 | 5 | |
2022 | Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors | Lin T.E.; Sung L.-C.; Chao M.-W.; Li M.; Zheng J.-H.; Sung T.-Y.; Hsieh J.-H.; CHIA-RON YANG ; Lee H.-Y.; Cho E.-C.; Hsu K.-C. | Journal of Enzyme Inhibition and Medicinal Chemistry | 3 | 3 | |
2021 | Synthesis and biological evaluation of phenothiazine derivative-containing hydroxamic acids as potent class II histone deacetylase inhibitors | Hsu K.-C.; Chu J.-C.; Tseng H.-J.; Liu C.-I.; Wang H.-C.; Lin T.E.; Lee H.-S.; LING-WEI HSIN ; Wang A.H.-J.; Lin C.-H.; Huang W.-J. | European Journal of Medicinal Chemistry | 9 | 6 |